600535:SHA
Tasly Pharmaceutical Group Co Ltd
CN¥15.95
arrow_downward
-0.31%(-0.050) 1D
Jul 23, 3:00:03 PM GMT+8 · CNY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
CN¥15.79
High
CN¥16.13
Low
CN¥15.76
Mkt. cap
23.90B
Avg. vol.
17.09M
Volume
21.84M
Dividend
1.94%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 29, 2026
P/E ratio
20.53
52-wk high
CN¥17.69
52-wk low
CN¥12.90
EPS
CN¥0.78
Shares outstanding
1.51B
No. of employees
11K
Open
CN¥15.79
High
CN¥16.13
Low
CN¥15.76
Mkt. cap
23.90B
Avg. vol.
17.09M
Volume
21.84M
Dividend
1.94%
Quarterly dividend
CN¥0.08
Ex-dividend date
May 29, 2026
P/E ratio
20.53
52-wk high
CN¥17.69
52-wk low
CN¥12.90
EPS
CN¥0.78
Shares outstanding
1.51B
No. of employees
11K
Related stocks
News stories
From sources across the web
MarketBeat
·
3 minutes ago
Newell Brands (NASDAQ:NWL) Shares Down 8.1% - Here's Why
The Motley Fool
·
Less than a minute ago
Is It Too Late to Buy the Vanguard S&P 500 ETF? Here's What History Says.
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd
AI content may include mistakes. Learn more